The Washington State Department of Health (DOH) aims to develop programs and services to help prevent illness and injury, promote healthy places to live and work, provide information to help people make good health decisions, and ensure Washington state is prepared for emergencies.
Washington State Department of Health
(DOH)
Public
Structural Relationships
-
Washington State Office of the Governor
(WA Governor) -
Washington State Department of Health
(DOH) -
Washington State Department of Health Substance Use Disorder Certification Advisory Committee
(WA DOH - SUD Certification Advisory Committee) -
Washington State Pharmacy Quality Assurance Commission
(WA Pharmacy Commission)
Information Set
- DOH - Active Rulemaking Projects [ InfoSet ]
Observations
The Week Ahead
(October 4, 2021)
WSLCB staff planned to host a third webinar on the Cannabis Central Reporting System (CCRS) to help expedite the transition away from MJ Freeway - and reallocate funding?
WSLCB - Board Caucus
(September 28, 2021) - Federal Legislation Review
A staff briefing on potential effects of a draft discussion bill to legalize cannabis federally prompted questions on engagement with the Washington state congressional delegation.
WA House COG - Committee Meeting
(April 1, 2019) - CBD Work Session
Industry, academic, and agency representatives brought lawmakers up to speed on CBD product research and policy development in Washington state.
WSLCB - Board Meeting
(September 15, 2021) - Summary
The board began rescinding unnecessary interim policies, heard rulemaking updates, and a licensee called for more time to transition from seed-to-sale traceability to weekly reporting.
WA Commission for Measurement of Tax Preferences - Public Meeting
(September 9, 2021) - Medical Cannabis
- USA - Washington
- Washington State Citizen Commission for Performance Measurement of Tax Preferences (WA Commission for Measurement of Tax Preferences)
A single patient offered testimony recommending sales tax breaks be reserved for registered patient purchases of DOH compliant products to incentivize “medical grade” production.
WSLCB - Board Meeting
(October 3, 2018) - HB 2334 Implementation - Public Hearing
A public hearing on the implementation of imported CBD rules drew suggested revisions on cannabis product testing standards from the public and a WSDA pesticide official.
WSLCB - Executive Management Team
(September 8, 2021) - Agency Request Legislation
The board heard about two agency request bills: a joint venture with WSDA to regulate testing lab standards and one “to allow for synthetic, but to prohibit artificial” cannabinoids in products.
WSLCB - Board Meeting
(August 22, 2018) - HB 2334 Implementation - CR-102
Following a longer development process than expected, a CR-102 on CBD imports for use as cannabis product additives was presented to board members and gained their approval.
The Week Ahead
(September 6, 2021)
Summer is “officially” over as judged by policymaking on traceability, 2022 legislation, synthesized cannabinoids, and medical cannabis taxation in the week ahead.
WA Commission for Measurement of Tax Preferences - Public Meeting
(August 3, 2021) - Medical Cannabis
- USA - Washington
- Washington State Citizen Commission for Performance Measurement of Tax Preferences (WA Commission for Measurement of Tax Preferences)
Commissioners learned about tax exemptions for medical patients and cooperatives, and the potentially dramatic impact of a statutory change redefining eligible cannabis purchases.